Epidemiological Study of Hospitalized Children for Pulmonary Tuberculosis at Strasbourg University Hospitals
NCT06110533 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 50
Last updated 2023-10-31
Summary
Pulmonary tuberculosis is the most common form of tuberculosis in children; According to the WHO, tuberculosis pulmonary tuberculosis in children represents approximately 80% of all cases of tuberculosis in children. In 2020, there were approximately 1.0 million new cases of pulmonary tuberculosis among children worldwide.
In France, childhood tuberculosis remains a rare disease; the most recent data show a rate of 3.3 cases per 100,000 inhabitants among children under 15 years old in 2019.
Pulmonary tuberculosis in children can lead to complications such as bronchiectasis and pneumothorax. Children living in homes where an adult has a active tuberculosis, or children with diseases chronic, malnourished or suffering from HIV are more likely to contract tuberculosis.
The aim of this research is to determine the incidence, identify the risk factors as well as the clinical forms of pulmonary tuberculosis in children hospitalized at Strasbourg University Hospitals between 2012 and 2022.
Conditions
- Pulmonary Tuberculosis
Sponsors & Collaborators
-
University Hospital, Strasbourg, France
lead OTHER
Eligibility
- Min Age
- 1 Year
- Max Age
- 17 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-04-04
- Primary Completion
- 2024-04-30
- Completion
- 2024-04-14
Countries
- France
Study Locations
More Related Trials
-
Community-based Tuberculosis Tracing and Preventive Therapy
NCT03832023 ·Status: COMPLETED ·Phase: NA
-
Determining Risk in Latent Tuberculosis
NCT01571739 ·Status: TERMINATED
-
Causes of FUO in Infants and Children
NCT04073108 ·Status: UNKNOWN
-
An Open Cohort of Childhood Tuberculosis in Mbarara National Referral Hospital, Uganda
NCT01422798 ·Status: COMPLETED
-
Impact of Systematic Early Tuberculosis Detection Using Xpert MTB/RIF Ultra in Children With Severe Pneumonia in High Tuberculosis Burden Countries (TB-Speed Pneumonia)
NCT03831906 ·Status: COMPLETED ·Phase: NA
-
Detection of Mycobacterium Tuberculosis in Blood of TB Patients and Their Contacts in Uganda
NCT06751706 ·Status: ENROLLING_BY_INVITATION
-
Triage UltraSound in Tb Endemic Regions
NCT05423847 ·Status: COMPLETED
-
Implementation of an Integrated Care Strategy for Children Contacts of Patients With Tuberculosis
NCT04331262 ·Status: COMPLETED
-
Relevance of Isoniazid Dosage in Adults Treated for Tuberculosis
NCT06054334 ·Status: UNKNOWN
-
Comparison Between Two Strategies for the Diagnosis of TB
NCT02961569 ·Status: COMPLETED ·Phase: NA
-
Patients With Tuberculosis, Mycobacteriosis or Latent Tuberculosis
NCT06764576 ·Status: RECRUITING
-
Epidemiological Study In Tuberculosis-Endemic Urban Area in Senegal
NCT03767946 ·Status: COMPLETED
-
Lipoarabinomannan (LAM) Enzyme-Linked Immunosorbent Assay (ELISA) in Diagnostics of Childhood Tuberculosis (TB)
NCT00512330 ·Status: UNKNOWN
-
Evaluation of Four Stool Processing Methods Combined With Xpert MTB/RIF Ultra for Diagnosis of Intrathoracic Paediatric TB (TB-Speed - Stool Processing)
NCT04203628 ·Status: COMPLETED ·Phase: NA
-
Stool Processing Kit (SPK) Evaluation for Pediatric Tuberculosis (TB)
NCT04899076 ·Status: COMPLETED
-
Window Prophylaxis for Pediatric Tuberculosis Prevention Trial
NCT07086820 ·Status: RECRUITING ·Phase: NA
-
Evaluation of a Novel Microbiological Diagnostic Test for Latent Mycobacterium Tuberculosis Infection
NCT06728930 ·Status: ENROLLING_BY_INVITATION
-
Evaluation of Pharmacokinetics and Safety Tolerability of Higher Doses of Rifampic
NCT04437836 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
TB Sequel: Pathogenesis and Risk Factors of Long-term Sequelae of Pulmonary TB
NCT03251196 ·Status: UNKNOWN
-
Improved Diagnostics for Paediatric Tuberculosis
NCT06944561 ·Status: COMPLETED ·Phase: NA
-
Pre- and Post-treatment Lung Microbiota, Metabolome and Immune Signatures at the Site of Disease in Patients With Active Pulmonary Tuberculosis
NCT04700579 ·Status: RECRUITING
-
Childhood TB Sequel
NCT05325125 ·Status: UNKNOWN
-
A Pragmatic Trial With Optimized Dose of Rifampicin and Moxifloxacin for the Treatment of Drug Susceptible Pulmonary Tuberculosis
NCT05575518 ·Status: RECRUITING ·Phase: PHASE3
-
Tuberculosis Cohort Avicenne Hospital
NCT05539014 ·Status: RECRUITING
-
Ultralow Dose Computed Tomography in High-risk Drug-resistant Tuberculosis Contacts
NCT02454738 ·Status: COMPLETED ·Phase: NA